Project Grant R01DA065972
Award Date 4/1/26
Completion Date 1/31/31
Dollars Obligated $748K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Atlanta, GA 30322, USA
Similar Awards
- Federal Project Grant Award Summary Emory University received a $670,712 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period July 1, 2025 through June 30, 2027. The grant supports a research study titled "Feasibility, Acceptability, and Validity of Remote Sweat-Derived Biomarker Collection," which aims to validate a novel non-invasive method for measuring systemic inflammation in people living...
- Federal Project Grant Award Summary New York University School of Medicine received a $771,043 Project Grant awarded on March 15, 2026, from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a hybrid Type II implementation-effectiveness trial designed to improve HIV prevention and substance use treatment outcomes for people who inject drugs. The primary deliverable is a social network-based peer change agent intervention called...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under its Drug Use and Addiction Research Programs (CFDA 93.279), awarded $109,652 to the University of Miami's Office of Research Administration on August 19, 2026, for an implementation research study examining telehealth delivery models for HIV and substance use disorder (SUD) care among people who inject drugs (PWID). This one-year project, scheduled for completion by August 18, 2027, will produce research...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Georgia Research Foundation, Inc. a Project Grant of $405,490 under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period July 15, 2025 through June 30, 2027. This research initiative will characterize chemsex patterns and adoption of harm reduction measures among men in the South, examining the relationship between drug use during sexual activity and risky sexual...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $7.09M Avenir Award Project Grant to the University of California, Los Angeles (UCLA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period July 1, 2025, through June 30, 2029. This research initiative addresses the critical gap between scientific evidence and policy implementation by developing innovative dissemination strategies to increase access to HIV prevention and...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $188,995.00 to the University of Pittsburgh under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 15, 2025, for the "Prescribe to Prevent HIV" (P2PH) trial, with a completion date of July 31, 2028. This project grant supports implementation research aimed at addressing the urgent health crisis of severe injection-related infections (SIRI), including HIV, among the estimated...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH) effective March 1, 2026 through February 28, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This four-year award supports research to evaluate the clinical impact and cost-effectiveness of integrating infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The research will deliver two primary...
- Federal Project Grant Award Summary Duke University received $586,517 in funding from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period September 1, 2025, through August 31, 2026. The award supports two integrated research initiatives: a primary project developing and testing Harm Reduction-Behavioral Activation (HR-BA) therapy as an adjunct to enhanced reentry primary care for individuals with post-incarceration drug...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of California, San Diego $1,573,958 under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025, through April 30, 2030. This Project Grant supports a hybrid Type I implementation trial titled "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening." The study delivers two primary interventions: (1)...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded J. David Gladstone Institutes a $1,343,271 Project Grant (CFDA 93.279, Drug Use and Addiction Research Programs) effective May 15, 2025, through March 31, 2030, to develop targeted small molecule recruitment strategies for suppressing the HIV transcriptionally active reservoir in individuals with substance use disorder (SUD). The research addresses a critical gap in antiretroviral therapy (ART), which fails to target latent...